Ewing sarcoma protein: A key player in human cancer

International Journal of Cell Biology

Volumn , Issue , 2013, Pages

  Paronetto, Maria Paola ^a,b  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; EWSR1 PROTEIN; MESSENGER RNA PRECURSOR; PROTEIN; RNA BINDING PROTEIN EWS; TAR DNA BINDING PROTEIN; TATA BINDING PROTEIN ASSOCIATED FACTOR; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

AMYOTROPHIC LATERAL SCLEROSIS; CANCER CELL; CANCER GROWTH; CANCER THERAPY; CHROMOSOME TRANSLOCATION; DNA DAMAGE; EWING SARCOMA; GENE EXPRESSION; GENE FUSION; GENE STRUCTURE; GENOMIC INSTABILITY; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RNA BINDING; RNA METABOLISM; RNA SPLICING; SPINAL MUSCULAR ATROPHY; TRANSCRIPTION ELONGATION; TRINUCLEOTIDE REPEAT;

EID: 84885339718     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2013/642853     Document Type: Review

References (102)

1. Aurias A., Rimbaut C., Buffe D., Translocation involving chromosome 22 in Ewing's sarcoma. A cytogenetic study of four fresh tumors. Cancer Genetics and Cytogenetics 1984 12 1 21 25 2-s2.0-0021262110 10.1016/0165-4608(84)90003-7 (Pubitemid 14110242)
2. Delattre O., Zucman J., Plougastel B., Desmaze C., Melot T., Peter M., Kovar H., Joubert I., De Jong P., Rouleau G., Aurias A., Thomas G., Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992 359 6391 162 165 2-s2.0-0026686674 10.1038/359162a0
3. Zucman J., Delattre O., Desmaze C., Epstein A. L., Stenman G., Speleman F., Fletchers C. D. M., Aurias A., Thomas G., EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genetics 1993 4 4 341 345 2-s2.0-0027183108 10.1038/ng0893-341 (Pubitemid 23231480)
4. Zucman J., Melot T., Desmaze C., Ghysdael J., Plougastel B., Peter M., Zucker J. M., Triche T. J., Sheer D., Turc-Carel C., Ambros P., Combaret V., Lenoir G., Aurias A., Thomas G., Delattre O., Combinatorial generation of variable fusion proteins in the Ewing family of tumours. EMBO Journal 1993 12 12 4481 4487 2-s2.0-0027438827 (Pubitemid 23330254)
5. Balamuth N. J., Womer R. B., Ewing's sarcoma. The Lancet Oncology 2010 11 2 184 192 2-s2.0-75249086827 10.1016/S1470-2045(09)70286-4
6. Kovar H., Downstream EWS/FLI1-upstream Ewing's sarcoma. Genome Medicine 2010 2 1, article 8 2-s2.0-78650720634 10.1186/gm129
7. Ordóñez J. L., Osuna D., Herrero D., De Álava E., Madoz-Gúrpide J., Advances in Ewing's sarcoma research: where are we now and what lies ahead? Cancer Research 2009 69 18 7140 7150 2-s2.0-70349753195 10.1158/0008-5472.CAN-08-4041
8. Lessnick S. L., Ladanyi M., Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. Annual Review of Pathology 2012 7 145 159 2-s2.0-84856870979 10.1146/annurev-pathol-011110-130237
9. Mackenzie I. R. A., Rademakers R., Neumann M., TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. The Lancet Neurology 2010 9 10 995 1007 2-s2.0-77956850818 10.1016/S1474-4422(10)70195-2
10. Vance C., Rogelj B., Hortobágyi T., De Vos K. J., Nishimura A. L., Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J., Williams K. L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P. N., Blair I. P., Nicholson G., De Belleroche J., Gallo J.-M., Miller C. C., Shaw C. E., Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009 323 5918 1208 1211 2-s2.0-61349162349 10.1126/science. 1165942
11. Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N., Ohki M., Genomic structure of the human RBP56/hTAF(II)68 and FUS/TLS genes. Gene 1998 221 2 191 198 2-s2.0-0032561520 10.1016/S0378-1119(98)00463-6 (Pubitemid 29023746)
12. Rossow K. L., Janknecht R., The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Research 2001 61 6 2690 2695 2-s2.0-0035866778 (Pubitemid 32685856)
13. Andersson M. K., Ståhlberg A., Arvidsson Y., Olofsson A., Semb H., Stenman G., Nilsson O., Åman P., The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response. BMC Cell Biology 2008 9, article 37 2-s2.0-48249083430 10.1186/1471-2121-9-37
14. Felsch J. S., Lane W. S., Peralta E. G., Tyrosine kinase Pyk2 mediates G-protein-coupled receptor regulation of the Ewing sarcoma RNA-binding protein EWS. Current Biology 1999 9 9 485 488 2-s2.0-0033529029 10.1016/S0960-9822(99) 80214-0 (Pubitemid 29228621)
15. Kwiatkowski T. J. Jr., Bosco D. A., LeClerc A. L., Tamrazian E., Vanderburg C. R., Russ C., Davis A., Gilchrist J., Kasarskis E. J., Munsat T., Valdmanis P., Rouleau G. A., Hosler B. A., Cortelli P., De Jong P. J., Yoshinaga Y., Haines J. L., Pericak-Vance M. A., Yan J., Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P. C., Horvitz H. R., Landers J. E., Brown R. H. Jr., Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science 2009 323 5918 1205 1208 2-s2.0-61349156118 10.1126/science.1166066
16. Bosco D. A., Lemay N., Ko H. K., Zhou H., Burke C., Kwiatkowski T. J. Jr., Sapp P., Mckenna-Yasek D., Brown R. H. Jr., Hayward L. J., Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Human Molecular Genetics 2010 19 21 4160 4175 2-s2.0-77957867303 10.1093/hmg/ddq335
17. Plougastel B., Zucman J., Peter M., Thomas G., Delattre O., Genomic structure of the EWS gene and its relationship to EWSR1, a site of tumor-associated chromosome translocation. Genomics 1993 18 3 609 615 2-s2.0-0027760934 10.1016/S0888-7543(05)80363-5 (Pubitemid 24021079)
18. Åman P., Panagopoulos I., Lassen C., Fioretos T., Mencinger M., Toresson H., Höglund M., Forster A., Rabbitts T. H., Ron D., Mandahl N., Mitelman F., Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS. Genomics 1996 37 1 1 8 2-s2.0-0030272143 10.1006/geno.1996.0513 (Pubitemid 26341827)
19. Crozat A., Aman P., Mandahl N., Ron D., Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma. Nature 1993 363 6430 640 644 2-s2.0-0027227651 10.1038/363640a0 (Pubitemid 23227627)
20. Melot T., Dauphinot L., Sévenet N., Radvanyi F., Delattre O., Characterization of a new brain-specific isoform of the EWS oncoprotein. European Journal of Biochemistry 2001 268 12 3483 3489 2-s2.0-0034823778 10.1046/j.1432-1327.2001.02251.x (Pubitemid 32862941)
21. Ota T., Suzuki Y., Nishikawa T., Complete sequencing and characterization of 21, 243 full-length human cDNAs. Nature Genetics 2004 36 1 40 45 10.1038/ng1285 (Pubitemid 38056206)
22. Kovar H., Jug G., Hattinger C., Spahn L., Aryee D. N. T., Ambros P. F., Zoubek A., Gadner H., The EWS protein is dispensable for Ewing tumor growth. Cancer Research 2001 61 16 5992 5997 2-s2.0-0035881569 (Pubitemid 32762526)
23. Li H., Watford W., Li C., Parmelee A., Bryant M. A., Deng C., O'Shea J., Sean B. L., Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development. Journal of Clinical Investigation 2007 117 5 1314 1323 2-s2.0-34248203558 10.1172/JCI31222 (Pubitemid 46718419)
24. Hicks G. G., Singh N., Nashabi A., Mai S., Bozek G., Klewes L., Arapovic D., White E. K., Koury M. J., Oltz E. M., Van Kaer L., Ruley H. E., Fus deficiency in mice results in defective B-lymphocyte development and activation, high levels of chromosomal instability and perinatal death. Nature Genetics 2000 24 2 175 179 2-s2.0-0033968408 10.1038/72842 (Pubitemid 30094720)
25. Kuroda M., Sok J., Webb L., Baechtold H., Urano F., Yin Y., Chung P., De Rooij D. G., Akhmedov A., Ashley T., Ron D., Male sterility and enhanced radiation sensitivity in TLS(-/-) mice. EMBO Journal 2000 19 3 453 462 2-s2.0-0034142209 (Pubitemid 30072615)
26. Mosmann T. R., Coffman R. L., TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 1989 7 145 173 2-s2.0-0024353079 (Pubitemid 19138011)
27. Cho J., Shen H., Yu H., Li H., Cheng T., Lee S. B., Lee B. C., Ewing sarcoma gene Ews regulates hematopoietic stem cell senescence. Blood 2011 117 4 1156 1166 2-s2.0-79251557792 10.1182/blood-2010-04-279349
28. Bertolotti A., Melot T., Acker J., Vigneron M., Delattre O., Tora L., EWS, but not EWS-FLI-1, is associated with both TFIID and RNA polymerase II: interactions between two members of the tet family, EWS and HTAF(II)68, and subunits of TFIID and RNA polymerase II complexes. Molecular and Cellular Biology 1998 18 3 1489 1497 2-s2.0-0031935157 (Pubitemid 28100914)
29. Bertolotti A., Lutz Y., Heard D. J., Chambon P., Tora L., hTAF(II)68, a novel RNA/ssDNA-binding protein with homology to the pro-oncoproteins TLS/FUS and EWS is associated with both TFIID and RNA polymerase II. EMBO Journal 1996 15 18 5022 5031 2-s2.0-0029812470 (Pubitemid 26315812)
30. Zhou H., Lee K. A. W., An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene. Oncogene 2001 20 12 1519 1524 2-s2.0-0035932382 10.1038/sj.onc.1204135 (Pubitemid 32291202)
31. Lee J., Rhee B. K., Bae G.-Y., Han Y.-M., Kim J., Stimulation of Oct-4 activity by Ewing's sarcoma protein. Stem Cells 2005 23 6 738 751 2-s2.0-20344371441 10.1634/stemcells.2004-0375 (Pubitemid 40791789)
32. Gascoyne D. M., Thomas G. R., Latchman D. S., The effects of Brn-3a on neuronal differentiation and apoptosis are differentially modulated by EWS and its oncogenic derivative EWS/Fli-1. Oncogene 2004 23 21 3830 3840 2-s2.0-2342635751 10.1038/sj.onc.1207497 (Pubitemid 38725696)
33. Thomas G. R., Latchman D. S., The pro-oncoprotein EWS (Ewing's sarcoma protein) interacts with the Brn-3a POU transcription factor and inhibits its ability to activate transcription. Cancer Biology and Therapy 2002 1 4 428 432 2-s2.0-1842843228 10.4161/cbt.1.4.23
34. Fujimura Y., Siddique H., Lee L., Rao V. N., Reddy E. S. P., EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function. Oncogene 2001 20 46 6653 6659 2-s2.0-0035845854 10.1038/sj.onc.1204684 (Pubitemid 33020594)
35. Araya N., Hirota K., Shimamoto Y., Miyagishi M., Yoshida E., Ishida J., Kaneko S., Kaneko M., Nakajima T., Fukamizu A., Cooperative interaction of EWS with CREB-binding protein selectively activates hepatocyte nuclear factor 4-mediated transcription. Journal of Biological Chemistry 2003 278 7 5427 5432 2-s2.0-0038662666 10.1074/jbc.M210234200 (Pubitemid 36801059)
36. Bailly R.-A., Bosselut R., Zucman J., Cormier F., Delattre O., Roussel M., Thomas G., Ghysdael J., DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma. Molecular and Cellular Biology 1994 14 5 3230 3241 2-s2.0-0028209984 (Pubitemid 24132736)
37. Li K. K. C., Lee K. A. W., Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain. Journal of Biological Chemistry 2000 275 30 23053 23058 2-s2.0-0034725703 10.1074/jbc.M002961200 (Pubitemid 30646195)
38. Alex D., Lee K. A. W., RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains. Nucleic Acids Research 2005 33 4 1323 1331 2-s2.0-14544271439 10.1093/nar/gki270 (Pubitemid 41439925)
39. Burd C. G., Dreyfuss G., Conserved structures and diversity of functions of RNA-binding proteins. Science 1994 265 5172 615 621 2-s2.0-0028129989 (Pubitemid 24268271)
40. Bertolotti A., Bell B., Tora L., The N-terminal domain of human TAF(II)68 displays transactivation and oncogenic properties. Oncogene 1999 18 56 8000 8010 2-s2.0-0033598946 (Pubitemid 30050561)
41. Ladomery M., Dellaire G., Multifunctional zinc finger proteins in development and disease. Annals of Human Genetics 2002 66 5-6 331 342 2-s2.0-0036866596 (Pubitemid 36004223)
42. Schwabe J. W. R., Rhodes D., Beyond zinc fingers: steroid hormone receptors have a novel structural motif for DNA recognition. Trends in Biochemical Sciences 1991 16 8 291 296 2-s2.0-0025745371 (Pubitemid 121004456)
43. Ohno T., Ouchida M., Lee L., Gatalica Z., Rao V. N., Reddy E. S. P., The EWS gene, involved in Ewing family of tumors, malignant melanoma of soft parts and desmoplastic small round cell tumors, codes for an RNA binding protein with novel regulatory domains. Oncogene 1994 9 10 3087 3097 2-s2.0-0028074607 (Pubitemid 24296791)
44. Tuerk C., Gold L., Systemic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 1990 249 4968 505 510 2-s2.0-0025194307
45. Lerga A., Hallier M., Delva L., Orvain C., Gallais I., Marie J., Moreau-Gachelin F., Identification of an RNA binding specificity for the potential splicing factor TLS. Journal of Biological Chemistry 2001 276 9 6807 6816 2-s2.0-0035794162 10.1074/jbc.M008304200
46. Ramos A., Hollingworth D., Pastore A., G-quartet-dependent recognition between the FMRP RGG box and RNA. RNA 2003 9 10 1198 1207 2-s2.0-0141631894 10.1261/rna.5960503 (Pubitemid 37151675)
47. Hanakahi L. A., Sun H., Maizels N., High affinity interactions of nucleolin with G-G-paired rDNA. Journal of Biological Chemistry 1999 274 22 15908 15912 2-s2.0-0033034413 10.1074/jbc.274.22.15908 (Pubitemid 29254971)
48. Oyoshi T., Kurokawa R., Structure of noncoding RNA is a determinant of function of RNA binding proteins in transcriptional regulation. Cell & Bioscience 2012 2 1, article 1
49. Ishii S., Imamoto F., Yamanashi Y., Characterization of the promoter region of the human c-erbB-2 protooncogene. Proceedings of the National Academy of Sciences of the United States of America 1987 84 13 4374 4378 2-s2.0-0343704701 (Pubitemid 17097838)
50. Pieler P., Theunissen O., TFIIA: nine fingers-three hands? Trends in Biochemical Sciences 1993 18 6 226 230 2-s2.0-0027280280 10.1016/0968-0004(93) 90194-R (Pubitemid 23167629)
51. Paronetto M. P., Miñana B., Valcárcel J., The Ewing sarcoma protein regulates DNA damage-induced alternative splicing. Molecular Cell 2011 43 3 353 368
52. Deloulme J. C., Prichard L., Delattre O., Storm D. R., The prooncoprotein EWS binds calmodulin and is phosphorylated by protein kinase C through an IQ domain. Journal of Biological Chemistry 1997 272 43 27369 27377 2-s2.0-0030774839 10.1074/jbc.272.43.27369 (Pubitemid 27452704)
53. Takahama K., Kino K., Arai S., Kurokawa R., Oyoshi T., Identification of Ewing's sarcoma protein as a G-quadruplex DNA- and RNA-binding protein. FEBS Journal 2011 278 6 988 998 2-s2.0-79952520900 10.1111/j.1742-4658.2011.08020.x
54. Araya N., Hiraga H., Kako K., Arao Y., Kato S., Fukamizu A., Transcriptional down-regulation through nuclear exclusion of EWS methylated by PRMT1. Biochemical and Biophysical Research Communications 2005 329 2 653 660 2-s2.0-14644437074 10.1016/j.bbrc.2005.02.018 (Pubitemid 40311793)
55. Hastings M. L., Krainer A. R., Pre-mRNA splicing in the new millennium. Current Opinion in Cell Biology 2001 13 3 302 309 2-s2.0-0035370845 10.1016/S0955-0674(00)00212-X (Pubitemid 32429494)
56. Rappsilber J., Ryder U., Lamond A. I., Mann M., Large-scale proteomic analysis of the human spliceosome. Genome Research 2002 12 8 1231 1245 2-s2.0-0036674269 10.1101/gr.473902 (Pubitemid 41264425)
57. Hackl W., Lührmann R., Molecular cloning and subcellular localisation of the snRNP-associated protein 69KD, a structural homologue of the proto-oncoproteins TLS and EWS with RNA and RNA-binding properties. Journal of Molecular Biology 1996 264 5 843 851 2-s2.0-0030596083 10.1006/jmbi.1996.0681 (Pubitemid 27019477)
58. Knoop L. L., Baker S. J., The splicing factor U1C represses EWS/FLI-mediated transactivation. Journal of Biological Chemistry 2000 275 32 24865 24871 2-s2.0-0034637482 10.1074/jbc.M001661200 (Pubitemid 30626591)
59. Michaud S., Reed R., A functional association between the 5′ and 3′ splice sites is established in the earliest prespliceosome complex (E) in mammals. Genes and Development 1993 7 6 1008 1020 2-s2.0-0027215924 (Pubitemid 23170825)
60. Zhang D., Paley A. J., Childs G., The transcriptional repressor, ZFM1 interacts with and modulates the ability of EWS to activate transcription. Journal of Biological Chemistry 1998 273 29 18086 18091 2-s2.0-0032541042 10.1074/jbc.273.29.18086 (Pubitemid 28334724)
61. Wu S., Green M. R., Identification of a human protein that recognizes the 3' splice site during the second step of pre-mRNA splicing. EMBO Journal 1997 16 14 4421 4432 2-s2.0-0030855063 10.1093/emboj/16.14.4421 (Pubitemid 27298195)
62. Yang L., Chansky H. A., Hickstein D. D., EWS · Fli-1 fusion protein interacts with hyperphosphorylated RNA polymerase II and interferes with serine-arginine protein-mediated RNA splicing. Journal of Biological Chemistry 2000 275 48 37612 37618 2-s2.0-0034353182 10.1074/jbc.M005739200 (Pubitemid 32004872)
63. Chansky H. A., Hu M., Hickstein D. D., Yang L., Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Research 2001 61 9 3586 3590 2-s2.0-0035328667 (Pubitemid 32694966)
64. Dutertre M., Sanchez G., De Cian M.-C., Barbier J., Dardenne E., Gratadou L., Dujardin G., Le Jossic-Corcos C., Corcos L., Auboeuf D., Cotranscriptional exon skipping in the genotoxic stress response. Nature Structural and Molecular Biology 2010 17 11 1358 1366 2-s2.0-78549288104 10.1038/nsmb.1912
65. Bentley D. L., Rules of engagement: co-transcriptional recruitment of pre-mRNA processing factors. Current Opinion in Cell Biology 2005 17 3 251 256 2-s2.0-19344378943 10.1016/j.ceb.2005.04.006 (Pubitemid 40719913)
66. Sanchez G., Bittencourt D., Laud K., Barbier J., Delattre O., Auboeuf D., Dutertre M., Alteration of cyclin D1 transcript elongation by a mutated transcription factor up-regulates the oncogenic D1b splice isoform in cancer. Proceedings of the National Academy of Sciences of the United States of America 2008 105 16 6004 6009 2-s2.0-43149105398 10.1073/pnas.0710748105 (Pubitemid 351758389)
67. Betticher D. C., Thatcher N., Altermatt H. J., Hoban P., Ryder W. D. J., Heighway J., Alternate splicing produces a novel cyclin D1 transcript. Oncogene 1995 11 5 1005 1011 2-s2.0-0029083790
68. Knudsen K. E., Alan Diehl J., Haiman C. A., Knudsen E. S., Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene 2006 25 11 1620 1628 2-s2.0-33645118564 10.1038/sj.onc.1209371
69. Sanchez G., Delattre O., Auboeuf D., Dutertre M., Coupled alteration of transcription and splicing by a single oncogene: boosting the effect on cyclin D1 activity. Cell Cycle 2008 7 15 2299 2305 2-s2.0-48849100548
70. Gregory R. I., Yan K.-P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R., The Microprocessor complex mediates the genesis of microRNAs. Nature 2004 432 7014 235 240 2-s2.0-9144225636 10.1038/nature03120 (Pubitemid 39545855)
71. Lee Y., Jeon K., Lee J.-T., Kim S., Kim V. N., MicroRNA maturation: stepwise processing and subcellular localization. EMBO Journal 2002 21 17 4663 4670 2-s2.0-0037009364 10.1093/emboj/cdf476 (Pubitemid 34984353)
72. Sohn E. J., Park J., Kang S. I., Wu Y. P., Accumulation of pre-let-7g and downregulation of mature let-7g with the depletion of EWS. Biochemical and Biophysical Research Communications 2012 426 1 89 93
73. Wang X., Arai S., Song X., Reichart D., Du K., Pascual G., Tempst P., Rosenfeld M. G., Glass C. K., Kurokawa R., Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008 454 7200 126 130 2-s2.0-46649093597 10.1038/nature06992 (Pubitemid 351934270)
74. Azzalin C. M., Reichenbach P., Khoriauli L., Giulotto E., Lingner J., Telomeric repeat-containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007 318 5851 798 801 2-s2.0-37349043972 10.1126/science.1147182 (Pubitemid 351411771)
75. Harper J. W., Elledge S. J., The DNA damage response: ten years after. Molecular Cell 2007 28 5 739 745 2-s2.0-36749022214 10.1016/j.molcel.2007.11.015 (Pubitemid 350217064)
76. Tybulewicz V. L. J., Crawford C. E., Jackson P. K., Bronson R. T., Mulligan R. C., Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene. Cell 1991 65 7 1153 1163 2-s2.0-0025780879 (Pubitemid 121001329)
77. Xu Y., Baltimore D., Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes and Development 1996 10 19 2401 2410 2-s2.0-0029821651 (Pubitemid 26341876)
78. Baarends W. M., van der Laan R., Grootegoed J. A., DNA repair mechanisms and gametogenesis. Reproduction 2001 121 1 31 39 2-s2.0-0035144873 (Pubitemid 32124514)
79. Hurov K. E., Cotta-Ramusino C., Elledge S. J., A genetic screen identifies the Triple T complex required for DNA damage signaling and ATM and ATR stability. Genes and Development 2010 24 17 1939 1950 2-s2.0-77956283656 10.1101/gad.1934210
80. O'Connell B. C., Adamson B., Lydeard J. R., Sowa M. E., Ciccia A., Bredemeyer A. L., Schlabach M., Gygi S. P., Elledge S. J., Harper J. Wade J. W., A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stability. Molecular Cell 2010 40 4 645 657 2-s2.0-78649316608 10.1016/j.molcel.2010.10.022
81. Klevernic I. V., Morton S., Davis R. J., Cohen P., Phosphorylation of Ewing's sarcoma protein (EWS) and EWS-Fli1 in response to DNA damage. Biochemical Journal 2009 418 3 625 634 2-s2.0-62149139782 10.1042/BJ20082097
82. Spahn L., Petermann R., Siligan C., Schmid J. A., Aryee D. N. T., Kovar H., Interaction of the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway. Cancer Research 2002 62 16 4583 4587 2-s2.0-0037101807
83. Muñoz M. J., Santangelo M. S. P., Paronetto M. P., de la Mata M., Pelisch F., Boireau S., Glover-Cutter K., Ben-Dov C., Blaustein M., Lozano J. J., Bird G., Bentley D., Bertrand E., Kornblihtt A. R., DNA damage regulates alternative splicing through inhibition of RNA polymerase II elongation. Cell 2009 137 4 708 720 2-s2.0-65549147264 10.1016/j.cell.2009.03.010
84. Falck J., Mailand N., Syljuåsen R. G., Bartek J., Lukas J., The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis. Nature 2001 410 6830 842 847 2-s2.0-0035848819 10.1038/35071124 (Pubitemid 32303786)
85. Zinszner H., Immanuel D., Yin Y., Liang F.-X., Ron D., A topogenic role for the oncogenic N-terminus of TLS: nucleolar localization when transcription is inhibited. Oncogene 1997 14 4 451 461 2-s2.0-0031035765 (Pubitemid 27087108)
86. Neumann M., Bentmann E., Dormann D., Jawaid A., Dejesus-Hernandez M., Ansorge O., Roeber S., Kretzschmar H. A., Munoz D. G., Kusaka H., Yokota O., Ang L.-C., Bilbao J., Rademakers R., Haass C., MacKenzie I. R. A., FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations. Brain 2011 134 9 2595 2609 2-s2.0-80052959701 10.1093/brain/awr201
87. Doi H., Okamura K., Bauer P. O., Furukawa Y., Shimizu H., Kurosawa M., Machida Y., Miyazaki H., Mitsui K., Kuroiwa Y., Nukina N., RNA-binding protein TLS is a major nuclear aggregate-interacting protein in Huntingtin exon 1 with expanded polyglutamine-expressing cells. Journal of Biological Chemistry 2008 283 10 6489 6500 2-s2.0-44449177217 10.1074/jbc.M705306200
88. Huey E. D., Ferrari R., Moreno J. H., Jensen C., Morris C. M., Potocnik F., Kalaria R. N., Tierney M., Wassermann E. M., Hardy J., Grafman J., Momeni P., FUS and TDP43 genetic variability in FTD and CBS. Neurobiology of Aging 2012 33 5 1016.e9 1016.e17 2-s2.0-84858334126 10.1016/j.neurobiolaging.2011.08.004
89. Ilieva H., Polymenidou M., Cleveland D. W., Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. Journal of Cell Biology 2009 187 6 761 772 2-s2.0-74049164709 10.1083/jcb.200908164
90. Cushman M., Johnson B. S., King O. D., Gitler A. D., Shorter J., Prion-like disorders: blurring the divide between transmissibility and infectivity. Journal of Cell Science 2010 123 8 1191 1201 2-s2.0-77951183978 10.1242/jcs.051672
91. Gitler A. D., Shorter J., RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 2011 5 3 179 187 2-s2.0-80052802585 10.4161/pri.5.3.17230
92. Alberti S., Halfmann R., King O., Kapila A., Lindquist S., A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009 137 1 146 158 2-s2.0-63049091236 10.1016/j.cell.2009.02.044
93. Toombs J. A., McCarty B. R., Ross E. D., Compositional determinants of prion formation in yeast. Molecular and Cellular Biology 2010 30 1 319 332 2-s2.0-73549115633 10.1128/MCB.01140-09
94. Couthouisa J., Harta M. P., Shorter J., DeJesus-Hernandez M., Erion R., Oristano R., Liu A. X., Ramos D., Jethava N., Hosangadi D., Epstein J., Chiang A., Diaz Z., Nakaya T., Ibrahim F., Kim H.-J., Solski J. A., Williams K. L., Mojsilovic-Petrovic J., Ingre C., Boylan K., Graff-Radford N. R., Dickson D. W., Clay-Falcone D., Elman L., McCluskey L., Greene R., Kalb R. G., Lee V. M.-Y., Trojanowski J. Q., Ludolph A., Robberecht W., Andersen P. M., Nicholson G. A., Blair I. P., King O. D., Bonini N. M., Van V. D., Rademakers R., Mourelatos Z., Gitler A. D., A yeast functional screen predicts new candidate ALS disease genes. Proceedings of the National Academy of Sciences of the United States of America 2011 108 52 20881 20890 2-s2.0-84855511889 10.1073/pnas.1109434108
95. Couthouis J., Hart M. P., Erion R., Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis. Human Molecular Genetics 2012 21 13 2899 2911
96. Venables J. P., Unbalanced alternative splicing and its significance in cancer. BioEssays 2006 28 4 378 386 2-s2.0-33645833000 10.1002/bies.20390
97. Orban T. I., Olah E., Emerging roles of BRCA1 alternative splicing. Molecular Pathology 2003 56 4 191 197 2-s2.0-0042067879 10.1136/mp.56.4.191 (Pubitemid 36981151)
98. Azuma M., Embree L. J., Sabaawy H., Hickstein D. D., Ewing sarcoma protein Ewsr1 maintains mitotic integrity and proneural cell survival in the zebrafish embryo. PLoS ONE 2007 2 10, article e979 2-s2.0-41549137834 10.1371/journal.pone.0000979 (Pubitemid 351472370)
99. Weaver B. A. A., Cleveland D. W., Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 2005 8 1 7 12 2-s2.0-22244478043 10.1016/j.ccr.2005.06.011 (Pubitemid 40991810)
100. Halder S. K., Anumanthan G., Maddula R., Mann J., Chytil A., Gonzalez A. L., Washington M. K., Moses H. L., Beauchamp R. D., Datta P. K., Oncogenic function of a novel WD-domain protein, STRAP, in human carcinogenesis. Cancer Research 2006 66 12 6156 6166 2-s2.0-33745700204 10.1158/0008-5472.CAN-05-3261
101. Anumanthan G., Halder S. K., Friedman D. B., Datta P. K., Oncogenic serine-threonine kinase receptor-associated protein modulates the function of ewing sarcoma protein through a novel mechanism. Cancer Research 2006 66 22 10824 10832 2-s2.0-33845333409 10.1158/0008-5472.CAN-06-1599 (Pubitemid 44876978)
102. Pahlich S., Quero L., Roschitzki B., Leemann-Zakaryan R. P., Gehring H., Analysis of Ewing Sarcoma (EWS)-binding proteins: interaction with hnRNP M, U, and RNA-helicases p68/72 within protein-RNA complexes. Journal of Proteome Research 2009 8 10 4455 4465 2-s2.0-70349972615 10.1021/pr900235t